Literature DB >> 3240728

Comparative study of ketanserin and hydrochlorothiazide in essential hypertension. Janssen Research Group.

I W Bayman1, S E Gould, J F Turner.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3240728     DOI: 10.2165/00003495-198800361-00028

Source DB:  PubMed          Journal:  Drugs        ISSN: 0012-6667            Impact factor:   9.546


× No keyword cloud information.
  5 in total

1.  Renal hemodynamic effects of ketanserin therapy in essential hypertension.

Authors:  C V Ram; D G Gonzalez; N M Kaplan; J M Ralakis; J D Henderson; C E Lugo; N Zachariah
Journal:  J Cardiovasc Pharmacol       Date:  1987       Impact factor: 3.105

2.  Adverse reactions to bendrofluazide and propranolol for the treatment of mild hypertension. Report of Medical Research Council Working Party on Mild to Moderate Hypertension.

Authors: 
Journal:  Lancet       Date:  1981-09-12       Impact factor: 79.321

3.  Ketanserin in essential hypertension: a double-blind, placebo-controlled study.

Authors:  H A Cameron; L E Ramsay
Journal:  Postgrad Med J       Date:  1985-07       Impact factor: 2.401

4.  A comparative study of ketanserin and metoprolol in essential hypertension.

Authors:  J A Kane; M Tooley; B Sibbald; S E Gould
Journal:  J Hypertens Suppl       Date:  1986-04

5.  Ketanserin: haemodynamic effects and mechanism of action.

Authors:  M A Schalekamp; A J Woittiez; G J Wenting; A H van den Meiracker; A J Man in 't Veld
Journal:  J Hypertens Suppl       Date:  1986-04
  5 in total
  1 in total

Review 1.  Ketanserin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in hypertension and peripheral vascular disease.

Authors:  R N Brogden; E M Sorkin
Journal:  Drugs       Date:  1990-12       Impact factor: 9.546

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.